Physical recovery across care pathways up to 12 months after hospitalization for COVID-19: A multicenter prospective cohort study (CO-FLOW)

[1]  W. Janssens,et al.  Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge , 2022, ERJ Open Research.

[2]  C. Denke,et al.  A Decade of Post-Intensive Care Syndrome: A Bibliometric Network Analysis , 2022, Medicina.

[3]  G. Ribbers,et al.  Symptoms persisting after hospitalisation for COVID-19: 12 months interim results of the CO-FLOW study , 2021, ERJ Open Research.

[4]  A. Divanoglou,et al.  Rehabilitation needs following COVID-19: Five-month post-discharge clinical follow-up of individuals with concerning self-reported symptoms , 2021, EClinicalMedicine.

[5]  Janet Diaz,et al.  A clinical case definition of post-COVID-19 condition by a Delphi consensus , 2021, The Lancet Infectious Diseases.

[6]  M. Spruit,et al.  One year follow-up of physical performance and quality of life in patients surviving COVID-19: a prospective cohort study. , 2021, Swiss medical weekly.

[7]  D. Needham,et al.  Physical, cognitive and mental health outcomes in 1-year survivors of COVID-19-associated ARDS , 2021, Thorax.

[8]  G. Ribbers,et al.  CO-FLOW: COvid-19 Follow-up care paths and Long-term Outcomes Within the Dutch health care system: study protocol of a multicenter prospective cohort study following patients 2 years after hospital discharge , 2021, BMC Health Services Research.

[9]  Ting Yu,et al.  1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study , 2021, The Lancet.

[10]  U. Merle,et al.  Persistent Symptoms in Adult Patients 1 Year After Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  Mark G. Jones,et al.  3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study , 2021, The Lancet Respiratory Medicine.

[12]  D. Brodie,et al.  Post-acute COVID-19 syndrome , 2021, Nature Medicine.

[13]  N. Ambrosino,et al.  Muscle Strength and Physical Performance in Patients Without Previous Disabilities Recovering From COVID-19 Pneumonia , 2020, American journal of physical medicine & rehabilitation.

[14]  B. Balbi,et al.  Low physical functioning and impaired performance of activities of daily life in COVID-19 patients who survived hospitalisation , 2020, European Respiratory Journal.

[15]  A. Harky,et al.  COVID-19 and Multiorgan Response , 2020, Current Problems in Cardiology.

[16]  Richard W. Bohannon.  Minimal clinically important difference for grip strength: a systematic review , 2019, Journal of physical therapy science.

[17]  Richard W. Bohannon,et al.  1-Minute Sit-to-Stand Test: SYSTEMATIC REVIEW OF PROCEDURES, PERFORMANCE, AND CLINIMETRIC PROPERTIES , 2019, Journal of cardiopulmonary rehabilitation and prevention.

[18]  René Rizzoli,et al.  Sarcopenia: revised European consensus on definition and diagnosis , 2018, Age and ageing.

[19]  Richard W. Bohannon,et al.  Minimal clinically important difference for change in 6‐minute walk test distance of adults with pathology: a systematic review , 2017, Journal of evaluation in clinical practice.

[20]  M. Puhan,et al.  A multicentre validation of the 1-min sit-to-stand test in patients with COPD , 2017, European Respiratory Journal.

[21]  R. Engelbert,et al.  de Morton Mobility Index Is Feasible, Reliable, and Valid in Patients With Critical Illness , 2016, Physical Therapy.

[22]  B. Saltin,et al.  The “Saltin–Grimby Physical Activity Level Scale” and its application to health research , 2015, Scandinavian journal of medicine & science in sports.

[23]  M. Koopmanschap,et al.  The iMTA Productivity Cost Questionnaire: A Standardized Instrument for Measuring and Valuing Health-Related Productivity Losses. , 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[24]  Richard W. Bohannon.  Muscle strength: clinical and prognostic value of hand-grip dynamometry , 2015, Current opinion in clinical nutrition and metabolic care.

[25]  Ian J. Deary,et al.  Grip Strength across the Life Course: Normative Data from Twelve British Studies , 2014, PloS one.

[26]  M. Puhan,et al.  Population-based reference values for the 1-min sit-to-stand test , 2013, International Journal of Public Health.

[27]  Linamara Rizzo Battistella,et al.  Sobre o processo de triagem em centros de reabilitação , 2010, Acta Fisiátrica.

[28]  J. Keating,et al.  The de Morton Mobility Index (DEMMI): An essential health index for an ageing world , 2008, Health and quality of life outcomes.

[29]  S. Ozalevli,et al.  Comparison of the Sit-to-Stand Test with 6 min walk test in patients with chronic obstructive pulmonary disease. , 2007, Respiratory medicine.

[30]  M. Poulain,et al.  6-minute walk testing is more sensitive than maximal incremental cycle testing for detecting oxygen desaturation in patients with COPD. , 2003, Chest.

[31]  Arthur S Slutsky,et al.  One-year outcomes in survivors of the acute respiratory distress syndrome. , 2003, The New England journal of medicine.

[32]  T. Mercer,et al.  Effects of exercise training on aerobic and functional capacity of end‐stage renal disease patients , 2002, Clinical physiology and functional imaging.

[33]  D L Sherrill,et al.  Reference equations for the six-minute walk in healthy adults. , 1998, American journal of respiratory and critical care medicine.

[34]  ATS statement: guidelines for the six-minute walk test. , 2002, American journal of respiratory and critical care medicine.

[35]  ATS Statement , 2002 .